Ataxia telangiectasia medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Ataxia telangiectasia}}
{{Ataxia telangiectasia}}
{{CMG}}
{{CMG}}


== Medical Therapy ==
== Medical Therapy ==
Line 10: Line 7:
Treatment is symptomatic and supportive. Physical and [[occupational therapy]] may help maintain flexibility. Speech therapy may also be needed. Gamma-globulin injections may be given to help supplement a weakened immune system. High-dose vitamin regimens may also be used.  Antibiotics are used to treat infections.  Some physicians recommend low doses of [[chemotherapy]] to reduce the risk of cancer but this is controversial.  It is also recommended that heterozygote family members are regularly monitored for cancers.
Treatment is symptomatic and supportive. Physical and [[occupational therapy]] may help maintain flexibility. Speech therapy may also be needed. Gamma-globulin injections may be given to help supplement a weakened immune system. High-dose vitamin regimens may also be used.  Antibiotics are used to treat infections.  Some physicians recommend low doses of [[chemotherapy]] to reduce the risk of cancer but this is controversial.  It is also recommended that heterozygote family members are regularly monitored for cancers.
Recently desferroxamine was shown to increase the stability of AT cells and may prove to be an effective treatment for the disorder.
Recently desferroxamine was shown to increase the stability of AT cells and may prove to be an effective treatment for the disorder.
<br>A cohort study has shown that most '''A-T''' patients suffering from malignancies, benefit from monthly transfusions of dexamethasone-loaded autologous erythrocytes. '''Allogeneic hematopoietic stem cell transplantation (alloHSCT)''' seems beneficial for preventing hematological malignancies and improving immunity, though due to its toxicity is not performed in '''A-T''' patients routinely.<ref name="titleAtaxia-Telangiectasia: Slack J, Albert MH, Balashov D, Belohradsky BH, Bertaina A, Bleesing J, et al. . Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders. J Allergy Clin Immunol.">{{cite web |url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215822/#B3}}</ref>


=== Genetic Counseling ===
=== Genetic Counseling ===

Latest revision as of 16:30, 12 June 2020

Ataxia telangiectasia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Ataxia telangiectasia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Diagnostic Studies

Treatment

Medical Therapy

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ataxia telangiectasia medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ataxia telangiectasia medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ataxia telangiectasia medical therapy

CDC on Ataxia telangiectasia medical therapy

Ataxia telangiectasia medical therapy in the news

Blogs on Ataxia telangiectasia medical therapy

Directions to Hospitals Treating Ataxia telangiectasia

Risk calculators and risk factors for Ataxia telangiectasia medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Medical Therapy

Treatment is symptomatic and supportive. Physical and occupational therapy may help maintain flexibility. Speech therapy may also be needed. Gamma-globulin injections may be given to help supplement a weakened immune system. High-dose vitamin regimens may also be used. Antibiotics are used to treat infections. Some physicians recommend low doses of chemotherapy to reduce the risk of cancer but this is controversial. It is also recommended that heterozygote family members are regularly monitored for cancers. Recently desferroxamine was shown to increase the stability of AT cells and may prove to be an effective treatment for the disorder.
A cohort study has shown that most A-T patients suffering from malignancies, benefit from monthly transfusions of dexamethasone-loaded autologous erythrocytes. Allogeneic hematopoietic stem cell transplantation (alloHSCT) seems beneficial for preventing hematological malignancies and improving immunity, though due to its toxicity is not performed in A-T patients routinely.[1]

Genetic Counseling

All individuals with AT should undergo genetic counseling along with their families. This is especially important due to the increased risk of cancers that heterozygotes have. There is also an associated risk to any other children born to the parents of the affected child.

References

  1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215822/#B3. Missing or empty |title= (help)

Template:WH

Template:WS